Blueprint Medicines
(NASDAQ:BPMC)
$45.98
0.75[1.66%]
Last update: 1:42PM (Delayed 15-Minutes)
Get Real Time Here
Day Range45.38 - 46.9452 Wk Range40.78 - 110.23Open / Close45.38 / -Float / Outstanding59.5M / 59.8M
Vol / Avg.238.4K / 709.8KMkt Cap2.8BP/E-50d Avg. Price52.82
Div / Yield-Payout Ratio-Total Float59.5MEPS-2.23

Blueprint Medicines Stock (NASDAQ:BPMC), Quotes and News Summary

Blueprint Medicines Stock (NASDAQ: BPMC) stock price, news, charts, stock research, profile.

Loading...
Day Range45.38 - 46.9452 Wk Range40.78 - 110.23Open / Close45.38 / -Float / Outstanding59.5M / 59.8M
Vol / Avg.238.4K / 709.8KMkt Cap2.8BP/E-50d Avg. Price52.82
Div / Yield-Payout Ratio-Total Float59.5MEPS-2.23
Seeking Alpha - Aug 16, 2022, 6:19PM
Seeking Alpha - Aug 1, 2022, 1:06PM
Sector: Health Care.Industry: Biotechnology
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-15
REV
Q3 2022Est.ActualSurprise
EPS-2.490-2.230 0.2600
REV43.370M65.977M22.607M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Blueprint Medicines (BPMC) stock?

A

You can purchase shares of Blueprint Medicines (NASDAQ: BPMC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Blueprint Medicines's (BPMC) competitors?

Q

What is the target price for Blueprint Medicines (BPMC) stock?

A

The latest price target for Blueprint Medicines (NASDAQ: BPMC) was reported by JMP Securities on Friday, November 4, 2022. The analyst firm set a price target for 114.00 expecting BPMC to rise to within 12 months (a possible 147.93% upside). 34 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Blueprint Medicines (BPMC)?

A

The stock price for Blueprint Medicines (NASDAQ: BPMC) is $45.98 last updated Today at November 29, 2022, 6:42 PM UTC.

Q

Does Blueprint Medicines (BPMC) pay a dividend?

A

There are no upcoming dividends for Blueprint Medicines.

Q

When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?

A

Blueprint Medicines’s Q4 earnings are confirmed for Wednesday, February 15, 2023.

Q

Is Blueprint Medicines (BPMC) going to split?

A

There is no upcoming split for Blueprint Medicines.

Q

What sector and industry does Blueprint Medicines (BPMC) operate in?

A

Blueprint Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.